This topic contains a solution. Click here to go to the answer

Author Question: Which of the following statements below inaccurately describes alpha? a. The lower the p-value, ... (Read 21 times)

Themember4

  • Hero Member
  • *****
  • Posts: 538
Which of the following statements below inaccurately describes alpha?
 
  a. The lower the p-value, the less likely the obtained differences are due to chance.
  b. The lower the p-value, the more likely the obtained differences are due to the IV.
  c. The lower the p-value, the more likely the obtained differences are due to chance.
  d. Both A and B.

Question 2

The first page of a manuscript is the __________.
 
  a. author note.
  b. title page.
  c. abstract.
  d. introduction.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

pocatato

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

C

Answer to Question 2

B




Themember4

  • Member
  • Posts: 538
Reply 2 on: Jul 13, 2018
Wow, this really help


JaynaD87

  • Member
  • Posts: 368
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Most strokes are caused when blood clots move to a blood vessel in the brain and block blood flow to that area. Thrombolytic therapy can be used to dissolve the clot quickly. If given within 3 hours of the first stroke symptoms, this therapy can help limit stroke damage and disability.

Did you know?

A seasonal flu vaccine is the best way to reduce the chances you will get seasonal influenza and spread it to others.

Did you know?

By definition, when a medication is administered intravenously, its bioavailability is 100%.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library